Clinical Trials Logo

Clinical Trial Summary

EPIFLO® unit along with standard wound care vs only standard wound care for Surgical site infections (SSI).


Clinical Trial Description

Anorectal procedures more often lead to surgical site infections. Such infections are unfortunately frequent and can be difficult for the patient and the treating physician. Wound hypoxia has been identified as a pathogenic mechanism behind wound infection and poor healing. Transdermal oxygen delivery (EPIFLO) is intended to promote the healing process in chronic wounds as an adjunct to standard wound care in wound management and treatment ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02617706
Study type Interventional
Source Neogenix, LLC dba Ogenix
Contact
Status Withdrawn
Phase Phase 2
Start date January 2017
Completion date January 2019